Biotech Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 December 7, 2020
Biotech Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma December 7, 2020
Biotech Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz® in Scandinavia December 7, 2020
Biotech Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin December 7, 2020
Biotech Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference December 7, 2020
Biotech Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis December 7, 2020
Biotech Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition December 7, 2020
Biotech Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox December 7, 2020
Biotech Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology December 7, 2020
Biotech Matinas BioPharma Files Preliminary Proxy for Special Meeting of Stockholders December 7, 2020
Search
biotech etf
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
